Observational study on the effects of IL-6 inhibitor therapy on adipokines in patients with rheumatoid arthritis
Phase of Trial: Phase IV
Latest Information Update: 02 Aug 2016
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Pharmacodynamics
- 11 May 2016 Status changed from completed to active, no longer recruiting.
- 02 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 23 Apr 2015 Planned End Date changed from 1 Sep 2015 to 1 Aug 2015 as reported by ISRCTN: Current Controlled Trials.